Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade

M. Shteinberg (Haifa, Israel)

Source: Virtual Congress 2021 – Respiratory infections
Session: Respiratory infections
Session type: State of the art session
Number: 1233

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shteinberg (Haifa, Israel). Antibiotic resistance in respiratory infections: challenges and actions for the upcoming decade. Virtual Congress 2021 – Respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Are antimicrobials still the future of respiratory infection therapy?
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021

Antibiotic resistance in pulmonary infections: mechanisms and epidemiology
Source: Eur Respir Monogr 2017; 75: 21-43
Year: 2017

Antibiotic resistance and clinical outcomes: the CAPNETZ experience
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006

Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines
Source: Eur Respir J 2011; 37: 112-118
Year: 2011

Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004

From the bedside: upcoming new clinical strategies: novel strategies to combat respiratory viral infections
Source: International Congress 2017 – Scientific year in review
Year: 2017

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones},
Source: Eur Respir J 2012; 40: 814-822
Year: 2012

Antibiotic prescribing in acute respiratory infections – are we following guidelines?
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Antibiotic stewardship in respiratory infections
Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats
Year: 2016

Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?
Source: Eur Respir J 2010; 35: 606-613
Year: 2010

International guidelines for nosocomial pneumonia: do they cover multidrug resistance management?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019

Future antibiotics and current practices for treating respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=255
Year: 2004

Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019

Empiric antibiotic treatment and pathogens resistance in respiratory tract infections; a prospective epidemiological survey
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003

Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012

Improved diagnostics and diagnostic approaches: The role in the fight to emerging infectious diseases (EID) and antimicrobial resistance (AMR)
Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions
Year: 2021

Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021

The challenges of severe pneumonia: new pathogens, new drugs and new formulations
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021

Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia?
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013